| Dr Kim R Gentry, MD | |
|
1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012-4705 | |
| (817) 394-4300 | |
| (817) 394-0200 |
| Full Name | Dr Kim R Gentry |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 40 Years |
| Location | 1001 N Waldrop Dr, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396736187 | NPI | - | NPPES |
| 081585402 | Medicaid | TX | |
| 098494004 | Medicaid | TX | |
| 00N91F | Other | TX | BCBS GRP |
| 8F7163 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | H7303 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Arlington Memorial Hospital | Arlington, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Digestive Disease Consultants Pllc | 3375531379 | 544 |
News Archive
A new study published in the journal Epigenetics in February 2020 reports that changes in the methylation status of the Presenilin 1 (PSEN1) gene could help diagnose Alzheimer's disease (AD) earlier. This study shows for the first time that methylation of this gene is a common feature in AD.
The number of overweight adolescents has doubled in the United States in the last three decades, and according to a new study there is a link between poverty and being overweight which is more discernable in the 15- to 17-year-old age group.
New results from The Environmental Determinants of Diabetes in the Young study show an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.
Most people are aware that light affects human behaviour and can be used to treat disorders such as Seasonal Affective Disorder, but now researchers from the University of Surrey and the University of Liege have found new evidence that light administered during the night immediately reduces sleepiness and boosts human brain function.
› Verified 9 days ago
| Entity Name | Texas Digestive Disease Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053397331 PECOS PAC ID: 3375531379 Enrollment ID: O20040505001844 |
News Archive
A new study published in the journal Epigenetics in February 2020 reports that changes in the methylation status of the Presenilin 1 (PSEN1) gene could help diagnose Alzheimer's disease (AD) earlier. This study shows for the first time that methylation of this gene is a common feature in AD.
The number of overweight adolescents has doubled in the United States in the last three decades, and according to a new study there is a link between poverty and being overweight which is more discernable in the 15- to 17-year-old age group.
New results from The Environmental Determinants of Diabetes in the Young study show an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.
Most people are aware that light affects human behaviour and can be used to treat disorders such as Seasonal Affective Disorder, but now researchers from the University of Surrey and the University of Liege have found new evidence that light administered during the night immediately reduces sleepiness and boosts human brain function.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kim R Gentry, MD Po Box 35629, Dallas, TX 75235-0629 Ph: (214) 424-2213 | Dr Kim R Gentry, MD 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012-4705 Ph: (817) 394-4300 |
News Archive
A new study published in the journal Epigenetics in February 2020 reports that changes in the methylation status of the Presenilin 1 (PSEN1) gene could help diagnose Alzheimer's disease (AD) earlier. This study shows for the first time that methylation of this gene is a common feature in AD.
The number of overweight adolescents has doubled in the United States in the last three decades, and according to a new study there is a link between poverty and being overweight which is more discernable in the 15- to 17-year-old age group.
New results from The Environmental Determinants of Diabetes in the Young study show an association between prolonged enterovirus infection and the development of autoimmunity to the insulin-producing pancreatic beta-cells that precedes type 1 diabetes.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.
Most people are aware that light affects human behaviour and can be used to treat disorders such as Seasonal Affective Disorder, but now researchers from the University of Surrey and the University of Liege have found new evidence that light administered during the night immediately reduces sleepiness and boosts human brain function.
› Verified 9 days ago
Dr. Waldo P Bracy Jr., M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012 Phone: 817-394-4300 Fax: 817-394-0200 | |
Thang D Le, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 800 W Randol Mill Rd Ste 2300, Arlington, TX 76012 Phone: 866-202-1032 Fax: 817-548-6649 | |
Dr. Hujefa Yusuf Vora, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3150 Matlock Rd, Suite 403, Arlington, TX 76015 Phone: 817-784-0052 Fax: 817-375-5800 | |
Dr. Raza Askari, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd Ste 210, Arlington, TX 76014 Phone: 817-375-5847 | |
Thuc Quyen Thi Nguyen, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd, Suite 210, Arlington, TX 76014 Phone: 817-417-4027 Fax: 817-417-4043 | |
Dr. Bienvenido Gatmaitan Gatmaitan, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 621 Matlock Centre Cir, Arlington, TX 76015 Phone: 817-860-6062 Fax: 817-795-6652 | |
Bernard A Mcgowen, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1217 Florida Dr, Suite 121, Arlington, TX 76015 Phone: 817-419-9155 Fax: 817-419-9412 |